MedTrace Logo

European Myeloma Network (EMN) Sample Project

NCT06237803 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 6000

Last updated 2025-12-03

No results posted yet for this study

Summary

This is an observational, non-interventional, multicenter study for the prospective collection, storage and analysis of patients' biological samples.

This study establishes a common international infrastructure useful to collect standard clinical variables at baseline and during treatment and to uniformly collect and store biological samples

Conditions

  • Multiple Myeloma
  • Smoldering Multiple Myeloma
  • Plasma Cell Leukemia
  • Extramedullary Myeloma
  • MGUS

Interventions

OTHER

storage of biological samples

collect and store biological samples

Sponsors & Collaborators

  • Janssen, LP

    collaborator INDUSTRY

  • European Myeloma Network B.V.

    lead NETWORK

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-21
Primary Completion
2037-12-31
Completion
2037-12-31

Countries

  • Australia
  • Austria
  • Belgium
  • Czechia
  • Greece
  • Ireland
  • Italy
  • Portugal
  • Serbia
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06237803 on ClinicalTrials.gov